Director Kenneth A. Burdick of LifeStance Health Group, Inc. filed a Form 4 on November 18, 2026, disclosing the sale of 124,228 shares of common stock on November 16, 2026.

Key Highlights

  • Shares sold: Kenneth A. Burdick disposed of 124,228 shares of LifeStance Health Group common stock on November 16, 2026.
  • Weighted average price: The reported sale price was $14.31 per share, a weighted average across multiple transactions ranging from $14.30 to $14.33 inclusive.
  • Remaining direct holdings: Following the transaction, Burdick directly held 3,472,038 shares of common stock.
  • Indirect holdings: An additional 46,511 shares are held indirectly through Burdick Family LLC.
  • Transaction code: The transaction was coded "S" (sale) in the filing.
  • Filer role: Burdick is identified as a Director of LifeStance Health Group, Inc. (NASDAQ:LFST).

Burdick Director Sale Details: LifeStance Health Group, November 2026

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 18, 2026, Kenneth A. Burdick, a Director of LifeStance Health Group, Inc. (NASDAQ:LFST), sold 124,228 shares of the company's common stock on November 16, 2026. The filing identifies the transaction code as "S," indicating a sale, with a weighted average price of $14.31 per share. The filing notes that the shares were sold in multiple transactions at prices ranging from $14.30 to $14.33 inclusive, and that Burdick "undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."

Following the reported transaction, Burdick directly held 3,472,038 shares of LifeStance Health Group common stock. The filing also discloses an indirect holding of 46,511 shares through an entity identified as Burdick Family LLC. No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Ryan Pardo as Attorney-in-Fact on November 18, 2026.

What Was Disclosed

The filing disclosed a sale of 124,228 shares of LifeStance Health Group common stock by Director Kenneth A. Burdick on November 16, 2026, at a weighted average price of $14.31 per share, with 3,472,038 shares held directly and 46,511 shares held indirectly through Burdick Family LLC after the transaction.